FindTrial
Sign In

Correlating the Clinical and CT Severity of COVID-19 patients with the Inflammatory markers and Co-morbidities

Correlating the Clinical and CT Severity of COVID-19 patients with the Inflammatory markers and Co-morbidities

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028836
Enrollment
200
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Aparna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients > 18 years who have tested positive for COVID-19 either by RT-PCR or CB-NAAT

Exclusion criteria

Exclusion criteria: Patients Patients with consolidation/pneumonia due to other organisms than the SARS CoV-2 virus. Patients with coexisting infections apart from COVID-19. Patients with chronically elevated inflammatory markers due to other inflammatory conditions, like Autoimmune conditions. Pregnant patients

Design outcomes

Primary

MeasureTime frame
Obtaining correlation between the inflammatory markers, comorbidities and the CT and Clinical severity of COVID-19 patients.Timepoint: At Baseline—

Secondary

MeasureTime frame
To develop a new classification system for COVID-19 patients by including their comorbidities and inflammatory marker levels into account.Timepoint: 1 year—

Countries

India

Contacts

Public ContactAparna Ganesh

Sri Ramachandra University

preetam_arthur@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026